Cancer Epigenetics Training (CET) Program
Cancer Epigenetics Training (CET) Program
批准号:
10646461
负责人:
PETER A JONES
金额:
$47.04万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-07-05 至 2026-06-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
This proposal seeks to develop a dedicated Cancer Epigenetics Training (CET) program at Van Andel
Research Institute (VARI) to train two new postdoctoral fellows per year for three years each. The objective
of the CET is to prepare 10 postdoctoral fellows to become independent academic and industry research
leaders in the field of cancer epigenetics. The CET program will build upon the Center for Epigenetics that
was established in 2014 by Peter Jones, Ph.D., D.Sc. (hon) and has grown into a world-class, internationally
recognized center of excellence for basic and translational epigenetics research. To launch the CET program,
we have assembled a team of 9 mentors and 6 co-mentors who collectively hold ~$5.7M of funding per year
and have highly complementary and interdisciplinary cancer and epigenetics expertise. CET faculty include
several epigenetics pioneers; two members of the National Academy of Sciences; the Van Andel Institute
Stand Up to Cancer Epigenetics Dream Team (VAI-SU2C); two leaders of The Cancer Genome Atlas (TCGA)
project; and mentors/co-mentors from all career stages. Trainees will be able to pursue basic and translational
research projects in cancer biology; tumorigenesis, cellular development and differentiation; mechanisms
governing DNA methylation and chromatin regulation; epigenomics and advanced tool development; GWAS
and EWAS; transgenerational inheritance; structural biology; metabolism; and epigenetic therapies. The CET
program is overseen by a dedicated Advisory Committee composed of domain-level experts from academic,
industrial, and clinical careers. We have developed a targeted diversity and recruitment plan to increase the
T32-eligible pool size and attract and retain individuals from underrepresented groups. Upon acceptance,
each Trainee is assigned an Individual Development Team (IDT) to coach, mentor, and guide the Trainee
through the scientific and non-scientific dimensions of career development. The faculty and CET Trainees are
supported by a dedicated Office of Postdoctoral Affairs that is directed by a PhD-level biomedical career
development professional. Each Trainee is required to complete a comprehensive curriculum of scientific and
professional development training. Key deliverables and milestones for T32 Trainees include annual seminars
(internal and external); at least one semester of teaching or mentoring experience; one first-authored
publication; and at least one submitted F32 (or equivalent) and K99/R00 application. The training
requirements and expectations are formalized within Individual Development Plans (IDPs) that are reviewed
annually by the Advisory Committee. Research-related, individualized training not otherwise defined in the
CET training program is provided by VARI. The CET will be rigorously evaluated through entrance, annual,
exit, and alumni assessments. With the superlative faculty, resources, and guidance afforded by the CET,
postdoctoral fellows will emerge with a comprehensive, multi-disciplinary skill set, perspective, and foundation
from which to establish their independent research careers in cancer epigenetics.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Cancer Epigenetics Training (CET) Program
-
批准号:10269565
-
项目类别:
-
资助金额:$14.39万
-
财政年份:2021
-
负责人:PETER A JONES
-
依托单位:
Cancer Epigenetics Training (CET) Program
-
批准号:10445044
-
项目类别:
-
资助金额:$30.65万
-
财政年份:2021
-
负责人:PETER A JONES
-
依托单位:
Targeting DNA Methylation and the Cancer Epigenome
-
批准号:10541829
-
项目类别:
-
资助金额:$109.5万
-
财政年份:2017
-
负责人:PETER A JONES
-
依托单位:
Establishing and Interpreting Abnormal DNA Methylation in Cancer
-
批准号:10732031
-
项目类别:
-
资助金额:$114.65万
-
财政年份:2017
-
负责人:PETER A JONES
-
依托单位:
Targeting DNA Methylation and the Cancer Epigenome
-
批准号:10320866
-
项目类别:
-
资助金额:$109.5万
-
财政年份:2017
-
负责人:PETER A JONES
-
依托单位:
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
-
批准号:7930202
-
项目类别:
-
资助金额:$4.99万
-
财政年份:2009
-
负责人:PETER A JONES
-
依托单位:
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
-
批准号:7931719
-
项目类别:
-
资助金额:$118.2万
-
财政年份:2009
-
负责人:PETER A JONES
-
依托单位:
Senior Leadership
-
批准号:7302427
-
项目类别:
-
资助金额:$28.73万
-
财政年份:2006
-
负责人:PETER A JONES
-
依托单位:
Developmental Funds
-
批准号:7302440
-
项目类别:
-
资助金额:$28.42万
-
财政年份:2006
-
负责人:PETER A JONES
-
依托单位:
Program Planning and Evaluation
-
批准号:7302433
-
项目类别:
-
资助金额:$3.25万
-
财政年份:2006
-
负责人:PETER A JONES
-
依托单位:
Cancer Center Administration
-
批准号:7302445
-
项目类别:
-
资助金额:$41.51万
-
财政年份:2006
-
负责人:PETER A JONES
-
依托单位:
Program Leaders of Research Programs
-
批准号:7302431
-
项目类别:
-
资助金额:$28.66万
-
财政年份:2006
-
负责人:PETER A JONES
-
依托单位:
Protocol Specific Research
-
批准号:7302590
-
项目类别:
-
资助金额:$7.8万
-
财政年份:2006
-
负责人:PETER A JONES
-
依托单位:
MOLECULAR MECHANISMS OF HUMAN BLADDER CARCINOGENESIS
-
批准号:6570919
-
项目类别:
-
资助金额:$130.19万
-
财政年份:2002
-
负责人:PETER A JONES
-
依托单位:
MOLECULAR MECHANISMS OF HUMAN BLADDER CARCINOGENESIS
-
批准号:6947238
-
项目类别:
-
资助金额:$139.94万
-
财政年份:2002
-
负责人:PETER A JONES
-
依托单位:
MOLECULAR MECHANISMS OF HUMAN BLADDER CARCINOGENESIS
-
批准号:6658093
-
项目类别:
-
资助金额:$133.2万
-
财政年份:2002
-
负责人:PETER A JONES
-
依托单位:
MOLECULAR MECHANISMS OF HUMAN BLADDER CARCINOGENESIS
-
批准号:6802204
-
项目类别:
-
资助金额:$136.57万
-
财政年份:2002
-
负责人:PETER A JONES
-
依托单位:
MOLECULAR MECHANISMS OF HUMAN BLADDER CARCINOGENESIS
-
批准号:7120488
-
项目类别:
-
资助金额:$140.04万
-
财政年份:2002
-
负责人:PETER A JONES
-
依托单位:
DE NOVO DNA METHYLATION IN BLADDER CANCER
-
批准号:7031633
-
项目类别:
-
资助金额:$30.41万
-
财政年份:2000
-
负责人:PETER A JONES
-
依托单位:
DE NOVO DNA METHYLATION IN BLADDER CANCER
-
批准号:7189345
-
项目类别:
-
资助金额:$29.56万
-
财政年份:2000
-
负责人:PETER A JONES
-
依托单位:
海外基金